Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infectionProceedings of the National Academy of Sciences - PNAS, 2020-03, Vol.117 (12), p.6771-6776 [Peer Reviewed Journal]Copyright National Academy of Sciences Mar 24, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1922083117 ;PMID: 32054787Full text available |
|
2 |
Material Type: Article
|
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitorsScience, 2020-04, Vol.368 (6489) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abb3405Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main proteaseScience, 2021-05, Vol.372 (6542) [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abf7945Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian CellsThe Journal of infectious diseases, 2021-08, Vol.224 (3), p.415-419 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiab247 ;PMID: 33961695Full text available |
|
5 |
Material Type: Article
|
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1AScience, 2021-02, Vol.371 (6532) [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abf4058Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2Science, 2021-07, Vol.373 (6554), p.541-547 [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;ISSN: 0036-8075 ;EISSN: 1095-9203 ;DOI: 10.1126/science.abi4708 ;PMID: 34326236Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Science, 2021-08, Vol.373 (6557) [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abg5827Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2The Journal of infectious diseases, 2020-10, Vol.222 (8), p.1289-1292 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiaa471 ;PMID: 32726430Full text available |
|
9 |
Material Type: Article
|
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusionProceedings of the National Academy of Sciences - PNAS, 2020-12, Vol.117 (50), p.32105-32113 [Peer Reviewed Journal]Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Dec 15, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2012197117 ;PMID: 33239446Full text available |
|
10 |
Material Type: Article
|
Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection ModelThe Journal of infectious diseases, 2021-09, Vol.224 (5), p.749-753 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiab361 ;PMID: 34244768Full text available |
|
11 |
Material Type: Article
|
Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infectionProceedings of the National Academy of Sciences - PNAS, 2020-10, Vol.117 (43), p.26915-26925 [Peer Reviewed Journal]Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Oct 27, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2001046117 ;PMID: 33046644Full text available |
|
12 |
Material Type: Article
|
Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome–Coronavirus 2 In Vitro When Administered After Virus InfectionThe Journal of infectious diseases, 2020-08, Vol.222 (5), p.722-725 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiaa350 ;PMID: 32559285Full text available |
|
13 |
Material Type: Article
|
Nucleoside Inhibitors of Zika VirusThe Journal of infectious diseases, 2016-09, Vol.214 (5), p.707-711 [Peer Reviewed Journal]Copyright © 2016 Oxford University Press on behalf of the Infectious Diseases Society of America ;The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiw226 ;PMID: 27234417Full text available |
|
14 |
Material Type: Article
|
Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19Proceedings of the National Academy of Sciences - PNAS, 2021-09, Vol.118 (36) [Peer Reviewed Journal]Copyright © 2021 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Sep 7, 2021 ;Copyright © 2021 the Author(s). Published by PNAS. 2021 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2105815118 ;PMID: 34413211Full text available |
|
15 |
Material Type: Article
|
Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replicationProceedings of the National Academy of Sciences - PNAS, 2018-07, Vol.115 (30), p.E7158-E7165 [Peer Reviewed Journal]Volumes 1–89 and 106–115, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright National Academy of Sciences Jul 24, 2018 ;2018 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1800525115 ;PMID: 29987044Full text available |
|
16 |
Material Type: Article
|
Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasionProceedings of the National Academy of Sciences - PNAS, 2022-03, Vol.119 (9), p.1 [Peer Reviewed Journal]Copyright © 2022 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Mar 1, 2022 ;Copyright © 2022 the Author(s). Published by PNAS. 2022 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2117198119 ;PMID: 35149555Full text available |
|
17 |
Material Type: Article
|
High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core proteinProceedings of the National Academy of Sciences - PNAS, 2015-12, Vol.112 (49), p.15196-15201 [Peer Reviewed Journal]Volumes 1–89 and 106–112, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright National Academy of Sciences Dec 8, 2015 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1513803112 ;PMID: 26598693Full text available |
|
18 |
Material Type: Article
|
Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroidsProceedings of the National Academy of Sciences - PNAS, 2020-01, Vol.117 (3), p.1700-1710 [Peer Reviewed Journal]Copyright National Academy of Sciences Jan 21, 2020 ;2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1910138117 ;PMID: 31896578Full text available |
|
19 |
Material Type: Article
|
Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targetsScience, 2021-07, Vol.373 (6551) [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abi5224Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapyProceedings of the National Academy of Sciences - PNAS, 2022-02, Vol.119 (6), p.1 [Peer Reviewed Journal]Copyright © 2022 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Feb 8, 2022 ;Copyright © 2022 the Author(s). Published by PNAS. 2022 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2120326119 ;PMID: 35110411Full text available |